MLAB — Mesa Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Mesa Laboratories, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	264	49.3	32.9	28.2	27.3
Net Total Accounts Receivable
Net Total Receivables	23.8	41.2	42.6	39.1	42
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	304	124	119	109	103
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	23.8	38.8	36.8	41.4	48.7
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	601	707	662	447	433
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	32.6	48.1	43.4	44.3	164
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	195	314	268	301	274
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	406	394	393	145	160
Total Liabilities & Shareholders' Equity	601	707	662	447	433
Total Common Shares Outstanding